Authors
Categories
  • Budget must ‘build to last’
    by Amar Ambani July 09, 2014 09:07 IST

    At a time when the economic scenario is being furiously debated, conventional wisdom may incline the decision maker to making a choice like ‘either Growth or Fiscal consolidation’, but notwithstanding the tough task at hand, a truly visionary leadership will need to pursue both growth and fiscal consolidation simultaneously.

  • Oil’s well, what about water?
    by R. Venkataraman July 02, 2010 17:16 IST

    The recent announcements of the Government, followed by the subsequent rally in oil stocks fills my heart with great joy. Years ago, I started my career as an oil and gas sector analyst. In mid 90s, it was mandatory for every oil & gas analyst to write one chapter on benefits of deregulation. Every analyst had put a BUY on all the PSU refining and marketing companies.

  • What if there is a cruel crude shock?
    by R. Venkataraman March 17, 2012 17:13 IST

    Crude in Rupee terms has again reached an all time high. This will force the government’s hand because rising crude has an impact on domestic inflation and current account deficit as we import most of our crude requirements. In my opinion, in the coming days we will see a steep increase in petrol and diesel prices. I pray and hope, we don’t have a situation that bad remains behind and worse begins.

  • India Gas update – Firing on all cylinders
    by Amar Ambani December 03, 2010 14:01 IST

    The Indian Gas sector is all set to scale new highs in consumption

  • Tuning the Midnight Oil China's quest for energy conservation
    by Amar Ambani December 21, 2009 11:12 IST

    Did you know China is the fifth-largest crude oil producer in the world? With domestic production supplying half of its crude oil demand, it commands a higher self sufficiency rate than most major economies of the West. Do read this update to get an insight about China’s Oil market…

Back to Top

  • Page
  • 1
 
 
Result Express
IIFL View
  • Thyrocare Tech.

    Thyrocare’s high B2B exposure helps it procure reagent at ~70% discount, thereby protecting margins. The 24% revenue ...

    Buy Reco. Price: 549.25

  • Syngene Intl.

    Syngene is moving up in the CRO value chain by expanding its research capabilities and foraying in API manufacturing in FY20E. ...

    Accumulate Reco. Price: 566.65